Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-interventional Post Marketing Safety Study Confirming Efficacy and Safety of Pentasa Slow Release Tablets in Patients With Ulcerative Colitis in Common Clinical Practice

NCT01104753 is registered in ClinicalTrials.gov with Ferring Pharmaceuticals as lead sponsor.

NCT NCT01104753
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01104753 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-interventional Post Marketing Safety Study Confirming Efficacy and Safety of Pentasa Slow Release Tablets in Patients With Ulcerative Colitis in Common Clinical Practice
Lead sponsor
Ferring Pharmaceuticals
Phase
Observational
Overall status
Completed
Start date
September 30, 2009
Completion date
March 31, 2011
Enrollment
338 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis